Charles River Laboratories International Inc.

01/21/2025 | News release | Distributed by Public on 01/22/2025 11:00

Unlocking the Advantages of Digital Pathology

Imagine an organization that only uses conventional analog pathology practices, ignoring transformative new technology that would enable them to streamline workflows and unlock deeper insights. On the other hand, their competitor is quick to adopt digital pathology - even with limited resources. Who will emerge as the market leader in the rapidly evolving landscape of nonclinical research?

Digital pathology solutions provide biopharma clients with a unique opportunity to gain a competitive edge and optimize resources, thanks to this innovative drug development technology. With pathology workflows expected to be fully digital in 2-3 years, and regulatory bodies moving towards digital pathology by guidelines issuance and compliance requirements, clients need a trusted partner not only on the cutting edge but driving it.

Knowing what to expect from a digital pathology partner can be another obstacle for clients that don't know where to start. This digital pathology e-guide provides you with everything you need to know about digital pathology in an easily accessible format to understand the benefits of shifting to a digital pathology workflow. Find out the questions that you need to consider when choosing your pathology partner, learn more about how digitally facilitated peer review and evaluation can connect you with pathologists around the globe and with your data in an instant, and arm yourself with valuable knowledge concerning validation to ensure regulatory compliance.

While conventional pathology methods are still effective, adopting a digital pathology workflow elevates your potential to set yourself apart from your competition.

Explore how Charles River's leading approach to digital pathology can help your transition to this innovative paradigm.

Begin your Journey